Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/06/2014 | US8716012 Alpha thymosin peptides as vaccine enhancers |
05/06/2014 | US8716011 Transcriptional control in Alicyclobacillus acidocaldarius and associated genes, proteins, and methods |
05/06/2014 | US8716002 Re-engineering bacteria for ethanol production |
05/06/2014 | US8715999 Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
05/06/2014 | US8715997 Variant Hypocrea jecorina CBH2 cellulases |
05/06/2014 | US8715993 Glycosidase enzymes |
05/06/2014 | US8715992 I-CreI meganuclease variants with modified specificity, method of preparation and uses thereof |
05/06/2014 | US8715991 DNA polymerases with increased 3'-mismatch discrimination |
05/06/2014 | US8715990 Glucose dehydrogenase and method for producing the dehydrogenase |
05/06/2014 | US8715989 Glucose dehydrogenase and method for producing the dehydrogenase |
05/06/2014 | US8715974 Method for producing scyllo-inositol |
05/06/2014 | US8715972 Homolactic fermentation from pentose |
05/06/2014 | US8715968 Methods and reagents for modulating cholesterol levels |
05/06/2014 | US8715963 Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris |
05/06/2014 | US8715962 Production of geranyl diphosphate |
05/06/2014 | US8715961 Methods of obtaining a specific binding member that binds eotaxin |
05/06/2014 | US8715959 Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
05/06/2014 | US8715940 Method of making recombinant influenza virus |
05/06/2014 | US8715925 Genetic test for the identification of carriers of complex vertebral malformations in cattle |
05/06/2014 | US8715922 Virus causing respiratory tract illness in susceptible mammals |
05/06/2014 | US8715696 Full genome DNA of human cytomegalovirus strain JHC isolated from Korean patient and open reading frames thereof |
05/06/2014 | US8715695 Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits |
05/06/2014 | US8715694 Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein |
05/06/2014 | US8715692 Modified RSV F proteins and methods of their use |
05/06/2014 | US8715691 Swine influenza hemagglutinin variants |
05/06/2014 | US8715690 Circovirus sequences associated with piglet weight loss disease (PWD) |
05/06/2014 | US8715688 Method for identification, isolation and production of antigens to a specific pathogen |
05/06/2014 | US8715687 Immunogenic composition comprising variants of Staphylococcal clumping factor A |
05/06/2014 | US8715683 RANK ligand polypeptides |
05/06/2014 | US8715668 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof |
05/06/2014 | US8715659 Single domain brain-targeting antibody fragments derived from llama antibodies |
05/06/2014 | US8715657 Therapeutic antibodies binding IL12Rβ1 |
05/06/2014 | US8715654 Methods of modulating the negative chemotaxis of immune cells |
05/06/2014 | US8715642 Modified viral vector particles |
05/06/2014 | US8715620 Treatment of asthma in mammals with clostridia neurotoxins |
05/06/2014 | CA2681294C Method for producing high-purity soluble thrombomodulin |
05/06/2014 | CA2651895C Plant artificial chromosome platforms via telomere truncation |
05/06/2014 | CA2621899C Aryl/alkyl succinic anhydride hyaluronan derivatives |
05/06/2014 | CA2602183C Production of carotenoids in oleaginous yeast and fungi |
05/06/2014 | CA2488059C Non-polymeric hematopoietic cell clots for delivery of active agents |
05/06/2014 | CA2475446C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
05/06/2014 | CA2459202C Adipose-derived stem cells and lattices |
05/06/2014 | CA2439175C Opiate receptors |
05/06/2014 | CA2401327C Nucleic acid formulations comprising poly-amino acids for gene delivery and methods of use |
05/06/2014 | CA2362963C Human suppressor of fused |
05/06/2014 | CA2287911C Apo-2 receptor |
05/01/2014 | WO2014066894A1 Biomarkers for nod2 and/or rip2 activity related application |
05/01/2014 | WO2014066892A1 De novo metabolic pathways for isoprene biosynthesis |
05/01/2014 | WO2014066851A1 C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders |
05/01/2014 | WO2014066848A1 Super-enhancers and methods of use thereof |
05/01/2014 | WO2014066808A1 Insulin-mimetic local therapeutic adjuncts for enhancing spinal fusion |
05/01/2014 | WO2014066796A2 Breast cancer prognosis signatures |
05/01/2014 | WO2014066700A1 Retroviral vector with mini-promoter cassette |
05/01/2014 | WO2014066670A1 Engineering of multi-carbon substrate utilization pathways in methanotrophic bacteria |
05/01/2014 | WO2014066663A1 Platelet targeted treatment |
05/01/2014 | WO2014066505A1 Double knockout (gt/cmah-ko) pigs, organs and tissues |
05/01/2014 | WO2014066498A1 Treatment of metastatic breast cancer |
05/01/2014 | WO2014066479A1 Pichia pastoris strains for producing predominantly homogeneous glycan structure |
05/01/2014 | WO2014066404A2 System and method for visualization of optimized protein expression |
05/01/2014 | WO2014066376A1 Method and materials for isolation of nucleic acid materials |
05/01/2014 | WO2014066328A1 Methods of treating neuroendocrine tumors using wnt pathway-binding agents |
05/01/2014 | WO2014066179A1 Template switch-based methods for producing a product nucleic acid |
05/01/2014 | WO2014065857A1 Plastid transformation using linear dna vectors |
05/01/2014 | WO2014065849A1 Rna targeted to beta catenin |
05/01/2014 | WO2014065758A1 A method of isolating nucleic acids in an aqueous sample using microfluidic device |
05/01/2014 | WO2014065642A1 Process for preparation and purification of recombinant human oncostatin m protein |
05/01/2014 | WO2014065596A1 Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof |
05/01/2014 | WO2014065552A1 Method for regulating adult skin stem cell differentiation |
05/01/2014 | WO2014065435A1 Method of efficiently establishing induced pluripotent stem cells |
05/01/2014 | WO2014065410A1 Method and kit for dna typing of hla gene |
05/01/2014 | WO2014065403A1 Anti-human cd40 monoclonal antibody, and use thereof |
05/01/2014 | WO2014065395A1 Rna preparation method |
05/01/2014 | WO2014065375A1 Method for inhibiting proliferation of cell by oxidative stress |
05/01/2014 | WO2014065323A1 Test method and test kit for psychiatric ailments |
05/01/2014 | WO2014065271A1 Recombinant cell and production method for isoprene |
05/01/2014 | WO2014065270A1 Tetrahydrooxazolo-pyridine derivative |
05/01/2014 | WO2014065253A1 High molecular weight pha-producing microbe and method of producing high molecular weight pha using same |
05/01/2014 | WO2014065210A1 Vaccine for preventing porcine edema disease |
05/01/2014 | WO2014065192A1 Nucleic acid extraction device and manufacturing method of said device, nucleic acid extraction method and nucleic acid sequence analysis method |
05/01/2014 | WO2014065047A1 Artificial bioluminescent enzyme |
05/01/2014 | WO2014065012A1 E-cadherin binding agent, protein synthesis inhibitor, cancer cell growth inhibitor, and antitumoral agent |
05/01/2014 | WO2014064711A2 Methods of administering raltegravir and raltegravir compositions |
05/01/2014 | WO2014064710A1 A process for the prepartion of non-viral vector for delivery of nucleic acids by mucosal route |
05/01/2014 | WO2014064705A2 Transgenic plants exhibiting improved resistance to abiotic stress |
05/01/2014 | WO2014064331A1 Novel esterases in the treatment of cellulosic and lignocellulosic material |
05/01/2014 | WO2014064277A1 Vector for liver-directed gene therapy of hemophilia and methods and use thereof |
05/01/2014 | WO2014064223A1 Method for specifically isolating nucleic acids |
05/01/2014 | WO2014064071A1 Method for plant improvement |
05/01/2014 | WO2014063832A1 Pr13.5 promoter for robust t-cell and antibody responses |
05/01/2014 | WO2014063753A1 Hyper-active factor ix vectors for liver-directed gene therapy of hemophilia 'b' and methods and use thereof |
05/01/2014 | WO2014063651A1 Method for purifying nucleic acid and kit |
05/01/2014 | WO2014063495A1 Rtrail mutant and monomethyl auristatin e conjugate thereof |
05/01/2014 | WO2014063442A1 Method for propagating sterile male plant line |
05/01/2014 | WO2014063368A1 Humanized monoclonal antibody in extracellular domain of anti-human death receptor 5 |
05/01/2014 | WO2014063271A1 Cotton ion channel protein, coding gene and uses thereof |
05/01/2014 | WO2014063270A1 Cotton ion channel class protein and coding gene and use thereof |
05/01/2014 | WO2014063269A1 Cotton casein kinase, and coding gene and application thereof |
05/01/2014 | WO2014063253A1 Anti-campylobacter jejuni antibodies and uses therefor |
05/01/2014 | WO2014055778A3 Multiprotein expression cassettes |
05/01/2014 | WO2014039809A3 Co-transcriptional assembly of modified rna nanoparticles |